Contact Us: 1-518-583-0095 
We’re Hiring… Join Our Team!
The Oncology Consortia of Criterium held their annual Investigator Meetings at the 2025 ASCO Annual Meeting. These gatherings foster an invaluable collaboration and innovation among leading experts in the field, across a wide range of institutions – driving forward our shared mission to advance cancer research and improve patient outcomes.
Continue reading
Learn about recent advances in cancer research across many areas, including myeloma, lung cancer, and pediatric cancers.
Continue reading
Over the past 10 years, the Academic Thoracic Oncology Medical Investigator Consortium has been at the forefront of conducting clinical trials in Thoracic Cancer using translational research methodologies. This research paper provides insights into the IIT process, and how pharmaceutical sponsors approve and support these trials.
Continue reading
As we step into 2025, the field of oncology is brimming with anticipation for several groundbreaking clinical trials. Here we explore some of the most promising upcoming oncology clinical trials that are set to make waves in the medical community.
Continue reading
In this article, we explore how to improve collaboration between biostatisticians and other researchers.
Continue reading
In this article, we review the current state of biostatistics in translational research, including in specialized oncology research.
Continue reading
Breast cancer remains a significant health concern worldwide, affecting millions of women and men each year. Learn more with this overview of breast cancer statistics for 2024, highlighting key facts and figures to raise awareness and promote early detection.
Continue reading
Dr. Deirdre Cohen and Dr. Robert Lentz, principal investigators with the Academic GI Cancer Consortium, attended the ASCO 2024 Annual Conference and shared valuable insights and progress from their innovative research model and clinical trials.
Continue reading
Cancer is recognized as one of the deadliest diseases due to the high prevalence and mortality rates across the globe. To address the limitations of existing treatment options, the concept of precision medicine, often known as personalized medicine, has emerged as a possible solution, which utilizes genomic knowledge to develop gene-targeted therapeutics.
Continue reading
Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC), and Dr. David Gerber, a member of ATOMIC and Associate Professor of Internal Medicine within the Hematology/Oncology Division at UT Southwestern Medical Center, discuss how a liberal arts education can serve as a foundation for a successful medical career, the benefits of face-to-face, personalized patient connections versus digital interactions, and the value in keeping a humble and service-focused approach when providing patient care.
Continue reading